JP2021500905A5 - - Google Patents

Download PDF

Info

Publication number
JP2021500905A5
JP2021500905A5 JP2020524042A JP2020524042A JP2021500905A5 JP 2021500905 A5 JP2021500905 A5 JP 2021500905A5 JP 2020524042 A JP2020524042 A JP 2020524042A JP 2020524042 A JP2020524042 A JP 2020524042A JP 2021500905 A5 JP2021500905 A5 JP 2021500905A5
Authority
JP
Japan
Prior art keywords
marker
cell
kit
marker component
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020524042A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500905A (ja
Filing date
Publication date
Priority claimed from GBGB1718088.6A external-priority patent/GB201718088D0/en
Application filed filed Critical
Publication of JP2021500905A publication Critical patent/JP2021500905A/ja
Publication of JP2021500905A5 publication Critical patent/JP2021500905A5/ja
Pending legal-status Critical Current

Links

JP2020524042A 2017-11-01 2018-10-31 ベクター Pending JP2021500905A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1718088.6 2017-11-01
GBGB1718088.6A GB201718088D0 (en) 2017-11-01 2017-11-01 Vectors
PCT/GB2018/053149 WO2019086865A1 (en) 2017-11-01 2018-10-31 Vectors

Publications (2)

Publication Number Publication Date
JP2021500905A JP2021500905A (ja) 2021-01-14
JP2021500905A5 true JP2021500905A5 (cg-RX-API-DMAC7.html) 2021-10-14

Family

ID=60580018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020524042A Pending JP2021500905A (ja) 2017-11-01 2018-10-31 ベクター

Country Status (15)

Country Link
US (1) US20210214748A1 (cg-RX-API-DMAC7.html)
EP (1) EP3703713A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021500905A (cg-RX-API-DMAC7.html)
KR (1) KR20200083554A (cg-RX-API-DMAC7.html)
CN (1) CN111278982A (cg-RX-API-DMAC7.html)
AU (1) AU2018361810A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020008771A2 (cg-RX-API-DMAC7.html)
CA (1) CA3080299A1 (cg-RX-API-DMAC7.html)
CL (1) CL2020001135A1 (cg-RX-API-DMAC7.html)
GB (1) GB201718088D0 (cg-RX-API-DMAC7.html)
IL (1) IL274278A (cg-RX-API-DMAC7.html)
MX (1) MX2020007225A (cg-RX-API-DMAC7.html)
RU (1) RU2020117772A (cg-RX-API-DMAC7.html)
SG (1) SG11202003682SA (cg-RX-API-DMAC7.html)
WO (1) WO2019086865A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12247060B2 (en) 2018-01-09 2025-03-11 Marengo Therapeutics, Inc. Calreticulin binding constructs and engineered T cells for the treatment of diseases
EP3765517A1 (en) 2018-03-14 2021-01-20 Elstar Therapeutics, Inc. Multifunctional molecules that bind to calreticulin and uses thereof
WO2020010250A2 (en) 2018-07-03 2020-01-09 Elstar Therapeutics, Inc. Anti-tcr antibody molecules and uses thereof
JP7579795B2 (ja) 2019-02-21 2024-11-08 マレンゴ・セラピューティクス,インコーポレーテッド NKp30に結合する抗体分子およびその使用
AU2020226893B2 (en) 2019-02-21 2025-02-27 Marengo Therapeutics, Inc. Multifunctional molecules that bind to T cell related cancer cells and uses thereof
WO2021138474A2 (en) 2020-01-03 2021-07-08 Marengo Therapeutics, Inc. Anti-tcr antibody molecules and uses thereof
CN115975945B (zh) * 2022-10-25 2025-10-28 苏州大学 荧光蛋白mKate2特异性标记的细胞外囊泡及其构建方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2207278T3 (es) * 1998-07-28 2004-05-16 Micromet Ag Heterominicuerpos.
PT2592148T (pt) * 2007-10-12 2018-11-12 Hoffmann La Roche Expressão proteica de múltiplos ácidos nucleicos
GB201501936D0 (en) * 2015-02-05 2015-03-25 Ucl Business Plc Signalling system
MX2018004721A (es) * 2015-10-23 2018-07-06 Eureka Therapeutics Inc Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas.

Similar Documents

Publication Publication Date Title
Yun et al. Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells
Quintarelli et al. Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia: Immunotherapy
Grassmann et al. Early emergence of T central memory precursors programs clonal dominance during chronic viral infection
Forconi et al. A new hope for CD56negCD16pos NK cells as unconventional cytotoxic mediators: an adaptation to chronic diseases
Eagle et al. ULBP6/RAET1L is an additional human NKG2D ligand
CN114616467B (zh) 筛选原代人类细胞中的同源t细胞和表位反应性的高通量方法
JP2021176313A (ja) 単一細胞の大規模並行コンビナトリアル分析のためのシステム及び方法
RU2020117772A (ru) Векторы
JP2022541181A5 (cg-RX-API-DMAC7.html)
Fuchs et al. Gene expression-based identification of antigen-responsive CD8+ T cells on a single-cell level
US11085917B2 (en) Methods for making novel antigen binding domains
CN105131126B (zh) 用于治疗恶性肿瘤的嵌合抗原受体及其制备方法与应用
Toffoli et al. Enhancement of NK cell antitumor effector functions using a bispecific single domain antibody targeting CD16 and the epidermal growth factor receptor
Hurtado et al. Efficient isolation of rare B cells using next-generation antigen barcoding
CN115835873A (zh) 用于产生表达重组受体的供体分批细胞的方法
Sytsma et al. Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells
Beura et al. Novel lymphocytic choriomeningitis virus strain sustains abundant exhausted progenitor CD8 T cells without systemic viremia
US20240190988A1 (en) Novel chimeric antigen receptors and libraries
Sundbäck et al. Cloning of minimally divergent allelic forms of the natural killer (NK) receptor Ly-49C, differentially controlled by host genes in the MHC and NK gene complexes
Ado et al. FB5P-seq-mAbs: monoclonal antibody production from FB5P-seq libraries for integrative single-cell analysis of B cells
Freitas Monteiro et al. NK cytotoxicity mediated by NK-92 cell lines expressing combinations of two allelic variants for FCGR3
CN105907783A (zh) 一种测试nk细胞活化的受体信号通路nkg2d荧光报告系统的构建方法及应用
CN120028543A (zh) 作为疫苗设计的表位选择工具的哺乳动物mhc肽展示
Iyer et al. CRISPR-mediated generation of a tumor-associated antigen-deficient Raji platform to investigate antigen loss in CAR-T cell therapy
CN117447604A (zh) 靶向c-Met的嵌合抗原受体及应用